Lifecore Biomedical, Inc. LFCR Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s other commercial liabilities?
- Lifecore Biomedical, Inc. (LFCR) reported other commercial liabilities of $13.48M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s other commercial liabilities changed year-over-year?
- Lifecore Biomedical, Inc.'s other commercial liabilities decreased by 38.6% year-over-year, from $21.96M to $13.48M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s other commercial liabilities?
- Over 2 years (2024 to 2026), Lifecore Biomedical, Inc.'s other commercial liabilities has grown at a -22.7% compound annual growth rate (CAGR), from $22.54M to $13.48M.